PCM
MCUR

Prelude Capital Management’s Macrocure Ltd. MCUR Stock Holding History

Prelude Capital Management’s Portfolio MCUR Stock Details MCUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500
Closed -$7K – 2110
2015
Q2 		$7K Buy
+500
New +$5.59K ﹤0.01% 1603

Other funds holding MCUR

ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Prelude Capital Management's MCUR Position: Q3 2015 in Review

Prelude Capital Management sold out of Macrocure Ltd. (MCUR) in Q3 2015, closing a stake of 500 shares — an estimated $7K sold.

Prelude Capital Management first reported a position in MCUR in Q2 2015 and held it in 1 quarter. The position peaked at $7K in Q2 2015. 9 funds tracked by Wall St. Rank hold MCUR as of Q3 2015.

  • Prelude Capital Management reported no remaining Macrocure Ltd. position as of Q3 2015 after selling out during the quarter.
  • Prelude Capital Management sold 500 Macrocure Ltd. shares in Q3 2015, an estimated $7K.
  • Prelude Capital Management first reported a position in Macrocure Ltd. in Q2 2015 and held it in 1 quarter.
  • Prelude Capital Management's Macrocure Ltd. position peaked at $7K in Q2 2015.
  • 9 funds tracked by Wall St. Rank held Macrocure Ltd. as of Q3 2015.

Based on Prelude Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.